Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Lorini

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancers|August 7, 2021
Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific TherapiesLuigi Lorini, Coro Bescós Atín, Selvam Thavaraj, et al.
Critical Reviews in Oncology/Hematology|April 28, 2025
Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challengesPablo Jiménez-Labaig, Luigi Lorini, Cristina Gurizzan, et al.
Scientific Reports|January 31, 2023
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathwaysChiara Romani, Luigi Lorini, Anna Bozzola, et al.
Oral Oncology|August 9, 2025
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disordersCristina Gurizzan, Armando G Licata, Luigi Lorini, et al.
BMC Cancer|May 18, 2021
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trialCristina Gurizzan, Luigi Lorini, Alberto Paderno, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Oral Oncology|August 11, 2023
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinomaElisabetta Roberti, Marco Merlano, Marco Ravanelli, et al.
Frontiers in Oncology|May 9, 2022
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant DisordersLuigi Lorini, Michele Tomasoni, Cristina Gurizzan, et al.
Frontiers in Oncology|November 1, 2021
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 PandemicCristina Gurizzan, Rebecca Pedersini, Carla Fornaro, et al.
Oral Oncology|February 14, 2022
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinomaDavide Lombardi, Michele Tomasoni, Luigi Lorini, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancers|August 7, 2021
Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific TherapiesLuigi Lorini, Coro Bescós Atín, Selvam Thavaraj, et al.
Critical Reviews in Oncology/Hematology|April 28, 2025
Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challengesPablo Jiménez-Labaig, Luigi Lorini, Cristina Gurizzan, et al.
Scientific Reports|January 31, 2023
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathwaysChiara Romani, Luigi Lorini, Anna Bozzola, et al.
Oral Oncology|August 9, 2025
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disordersCristina Gurizzan, Armando G Licata, Luigi Lorini, et al.
BMC Cancer|May 18, 2021
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trialCristina Gurizzan, Luigi Lorini, Alberto Paderno, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Oral Oncology|August 11, 2023
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinomaElisabetta Roberti, Marco Merlano, Marco Ravanelli, et al.
Frontiers in Oncology|May 9, 2022
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant DisordersLuigi Lorini, Michele Tomasoni, Cristina Gurizzan, et al.
Frontiers in Oncology|November 1, 2021
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 PandemicCristina Gurizzan, Rebecca Pedersini, Carla Fornaro, et al.
Oral Oncology|February 14, 2022
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinomaDavide Lombardi, Michele Tomasoni, Luigi Lorini, et al.
Pageof 5